ARCHIVES

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981